Skip to main content

Table 2 Content of interviews and types, and numbers of interviewees

From: Bridging the gap between basic science and clinical practice: a role for community clinicians

Early phase one interviewsa Later phase two interviewsb Type of intervieweec Number of interviews
(total = 243)
Incentives and disincentives for provider participation, including organizational barriers and motivators Best practices in community research networks, and how new provider networks might partner with these Community clinicians (Individual primary care clinicians, dentists, nurse practitioners) and clinician organizations (health plans, large community practices) not currently participating in research 37
Strategies for provider participation and retention Proposed provider effort as complementary to or in competition with existing clinician organizations; Liability and marketing concerns Individual clinicians and health provider organizations already participating in clinical research 30
Ethical and professional issues Optimal design for studies in community practices; Costs associated with conducting various types of clinical research studies in community settings Leaders and coordinators of clinical research networks (e.g., CCOPs, AMC leaders, PBRNs) 80
Advantages and limitations of different types of research networks/organizations by study and provider type and the potential role of emerging information systems Governance, oversight, and quality control for NCRA Representatives of private-sector organizations (e.g., CROs) and stakeholders (e.g., professional associations, pharmaceutical companies) with relevant experience and interest 77
Specific recommendations to NIH on design of physician recruitment and incentives Addressing privacy, HIPAA and institutional review boards issues Representatives of public and government entities (e.g., leaders from NIH institutes and other federal agencies) with relevant experience and interest 19
  1. a A list of key issues discussed during early phases of interviews. See Appendix 1 for list of early phase interview informants.
  2. b A list of key issues discussed during later interviews, after review of transcripts of early interviews. See Appendix 2 for list of later phase interview informants.
  3. c Interviewees were selected from a listing developed by key stakeholders, authors of pertinent publications, recommendations by national organizations, and by recommendations by NIH Institute Leaders. Contact with members of this list, supplemented by snowball sampling, was used to generate the list of interviewees table.